Part 2: The Spaces Between
Bright Frontier, a new platform founded by Janis Naeve and Tim Fitzpatrick, maps systemic gaps in kidney and cardiometabolic (CKM) care and proposes four critical "bridges"—signal to decision, decision to action, action to accountability, and accountability to signal. The analysis highlights that only a fraction of high‑risk patients receive proven therapies such as SGLT2 inhibitors, and that fragmented data and payment models impede early intervention. Over $20 billion in recent kidney‑related M&A and more than $3 billion in early‑stage CKM infrastructure funding signal strong investor belief in upstream solutions. The series calls for coordinated investment to build the connective infrastructure that will translate insights into outcomes.
Inside the RPA's Leadership Development Program
In this episode Tim Fitzpatrick chats with three early‑career nephrologists—Kinjal Shastri, Amandeep (Aman) Raman, and Raman Benaktar—about their recent participation in the Renal Physicians Association’s Leadership Development Program. The fellows explain that the year‑long fellowship pairs them with senior mentors,...